Recent 8-K filings for BMEA

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 11, 2026 20:58 UTC earnings item 2.02item 9.01

  Biomea Fusion Q1 net loss $12.4M; cash $45.1M; icovamenib Phase II T2D data due Q4 2026

source · BMEA on sec.gov